Sponsor:
Hikari Dx, Inc.
Code:
NCT06710262
Conditions
Antiplatelet Therapy
Healthy Donors
Von Willebrand Disease (VWD)
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
T-TAS PL Assay
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Hikari Dx, Inc. on 2025-03-12.